BioInfra Co.,Ltd.

Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.

199730 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층, 용인시
Website:: http://bioinfra.co.kr/?lang=en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioInfra Co., Ltd. is a global healthcare and biotechnology company focused on advancing human health through innovative solutions for disease prevention and treatment. The company's core activities are centered on two primary business segments: diagnostics development and contract research organization (CRO) services. Its flagship product is a proprietary multi-biomarker blood test, a screening technology designed for the early detection of risk for eight major types of cancer. The company's CRO division provides comprehensive support to the pharmaceutical industry, offering services that include Phase 1 clinical trials, bioequivalence testing, immunoassays, and pharmaceutical quality inspections.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioInfra Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioInfra Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioInfra Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Lytix Biopharma AS Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.	Norway	LYTIX
MaaT Pharma Developing gut microbiome therapies to improve survival for cancer patients.	France	MAAT
Mabion S.A. Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.	Poland	MAB
Magle Chemoswed Holding AB A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.	Sweden	MAGLE
Mainz BioMed N.V. Develops at-home diagnostic tests for the early detection of life-threatening cancers.	Germany	N/A
Marinomed Biotech AG Develops virus-blocking products & immunology therapies via proprietary technology platforms.	Austria	MARI
Matricelf Ltd. Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.	Israel	MTLF
Median Diagnostics Inc. Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.	South Korea	233250
MediciNova,Inc. Developing small-molecule drugs for neurology, respiratory, and liver diseases.	Japan	4875
Medicon Hellas S.A. Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.	Greece	MEDIC